JESSICA FREIBERGER: Open Payments
NPI 1568814234 · SAINT CLAIR, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$565 in 29 payments from 13 companies in 2025. Trend: 2023 $512 · 2024 $414 · 2025 $565
Food & beverage: $565
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $125 |
| ABBVIE INC. | 6 | $117 |
| Neurocrine BioSciences, Inc. | 4 | $92 |
| Lilly USA, LLC | 2 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Xeris Pharmaceuticals, Inc. | 2 | $31 |
| Dexcom, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
Products named: INGREZZA, VRAYLAR, Wegovy, MOUNJARO, Rybelsus, REXULTI, QULIPTA, GVOKE HYPOPEN.
Industry payments across MO — which companies pay providers there.
